Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Rizzo, Robertaa; * | Bortolotti, Dariaa | Gentili, Valentinaa | Rotola, Antonellaa | Bolzani, Silviaa | Caselli, Elisabettaa | Tola, Maria Rosariab | Di Luca, Darioa; *
Affiliations: [a] Department of Medical Sciences, University of Ferrara, Ferrara, Italy | [b] Department of Neurosciences and Rehabilitation, University Hospital, Arcispedale S. Anna, Ferrara, Italy
Correspondence: [*] Correspondence to: Prof. Dario Di Luca and Prof. Roberta Rizzo, University of Ferrara, Department of Medical Sciences, Section of Microbiology and Medical Genetics, Via Luigi Borsari, 46 - 44121 Ferrara, Italy. Tel.: +39 0532455318; Fax: +39 0532974470; E-mail: [email protected] (Dario Di Luca) and Tel.: +39 0532455382; Fax: +39 0532974470; E-mail: [email protected] (Roberta Rizzo).
Abstract: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, where neuroinflammation and immune cells are key pathological factors. Recently, it was suggested a possible association between AD and human herpesvirus 6 (HHV-6) infection. Since we recently observed that multiple sclerosis patients with KIR2DL2 expression on natural killer (NK) cells are more susceptible to herpesvirus infection, we tested the possible implication of KIR/HLA genetic for HHV-6A infection. We identified, for the first time, a possible implication of a specific KIR/HLA subset in AD. The combination KIR2DS2/KIR2DL2/C1 correlated with a lower MMSEDi score, representative of a severe AD status and an increased susceptibility to HHV-6A infection. Therefore, the results seem to converge on the hypothesis that herpesvirus infection might play a role in AD. If this hypothesis finds experimental confirmation, a new therapeutic strategy, modulating KIR2DL2 expression on NK cells, for AD might be envisaged.
Keywords: Alzheimer’s disease, herpesvirus, HHV-6A, KIR, NK cell
DOI: 10.3233/JAD-180777
Journal: Journal of Alzheimer's Disease, vol. 67, no. 4, pp. 1379-1389, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]